Clinical Performance of a Silicone Hydrogel Lens With Use of FID 114675A
Primary Purpose
Contact Lens Fit, Myopia
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
FID 114675A multi-purpose disinfecting solution (MPDS)
renu fresh Multi-Purpose Solution (MPS)
Galyfilcon A contact lenses (Acuvue Advance)
Sponsored by
About this trial
This is an interventional supportive care trial for Contact Lens Fit focused on measuring Contact Lens Wear, Contact Lens Solution, Multi-purpose disinfecting solution, Myopia
Eligibility Criteria
Inclusion Criteria:
- 18 years of age or older.
- History of at least 5 days successful daily wear (minimum 8 hours per day) of spherical, single power Acuvue® Advance® SiH contact lenses prior to Visit 1.
- Wear contact lenses a minimum of 8 hours per day prior to Visit 1.
- Vision correctable to 20/30 (Snellen) or better in each eye at distance with study lenses at Visit 1.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Need to wear contact lenses on an extended wear basis (i.e., overnight) during the study.
- Use of products other than a multi-purpose solution to care for lenses at least 7 days prior to Visit 1. Pre-study use of rewetting drops is acceptable.
- History of intolerance or known sensitivity to any component of the treatments.
- Use of over-the-counter (OTC) or prescribed topical ocular medications within 7 days prior to Visit 1.
- Other protocol-defined exclusion criteria may apply.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
FID 114576A / renu fresh
renu fresh / FID 114675A
Arm Description
FID 114675A used for contact lens care per protocol-specified instructions for 14 days, followed by a minimum 1-day washout period, after which renu fresh used for contact lens care for an additional 14 days.
Renu fresh used for contact lens care per protocol-specified instructions for 14 days, followed by a minimum 1-day washout period, after FID 114675A used for contact lens care for an additional 14 days.
Outcomes
Primary Outcome Measures
Lens Fit
As assessed by the investigator using a composite score based on three lens fit measures: static, push-up, and centration. Static and pushup were assessed on a 5-point scale, where -2=reduced movement unacceptable, -1=reduced movement acceptable, 0=optimal movement, 1=excessive movement acceptable, 2=excessive movement unacceptable. Centration was assessed on a 3-point scale, where 0=optimal lens centration, 1=acceptable decentration, 2=unacceptable decentration. A subject with an assessment of optimal or acceptable for each measure was considered acceptable on all measurements.
Secondary Outcome Measures
Mean Change From Baseline for Circumlimbal Conjunctival Staining Sum Score
The bulbar conjunctiva was assessed by the investigator at baseline and Day 14 utilizing a slit-lamp and ophthalmic dye. Staining coverage was scored separately in each of four regions (nasal, temporal, inferior, and superior) using a 5-point photographic reference scale, where 0=0.00% coverage and 4=10% or greater coverage. The scores for the four regions were summed, with a sum score range of 0-16.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01240135
Brief Title
Clinical Performance of a Silicone Hydrogel Lens With Use of FID 114675A
Official Title
Clinical Performance of a Marketed Silicone Hydrogel Contact Lens When Used With Silicone Hydrogel MPDS FID 114675A
Study Type
Interventional
2. Study Status
Record Verification Date
June 2012
Overall Recruitment Status
Completed
Study Start Date
October 2010 (undefined)
Primary Completion Date
February 2011 (Actual)
Study Completion Date
February 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Alcon Research
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate the clinical performance of a silicone hydrogel contact lens when used with an investigational multi-purpose disinfecting solution (MPDS).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Contact Lens Fit, Myopia
Keywords
Contact Lens Wear, Contact Lens Solution, Multi-purpose disinfecting solution, Myopia
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
89 (Actual)
8. Arms, Groups, and Interventions
Arm Title
FID 114576A / renu fresh
Arm Type
Other
Arm Description
FID 114675A used for contact lens care per protocol-specified instructions for 14 days, followed by a minimum 1-day washout period, after which renu fresh used for contact lens care for an additional 14 days.
Arm Title
renu fresh / FID 114675A
Arm Type
Other
Arm Description
Renu fresh used for contact lens care per protocol-specified instructions for 14 days, followed by a minimum 1-day washout period, after FID 114675A used for contact lens care for an additional 14 days.
Intervention Type
Device
Intervention Name(s)
FID 114675A multi-purpose disinfecting solution (MPDS)
Other Intervention Name(s)
Alcon Multi-Purpose Disinfecting Solution (MPDS)
Intervention Description
Daily regimen, 14 days: Thoroughly wet and rub each side of study contact lens for 10 seconds, rinse each side of the lens for 10 seconds, and soak contact lens for at least 6 hours.
Intervention Type
Device
Intervention Name(s)
renu fresh Multi-Purpose Solution (MPS)
Other Intervention Name(s)
Bausch + Lomb renu® fresh™ Multi-Purpose Solution
Intervention Description
Daily regimen, 14 days: Wet study contact lens with 3 drops and rub each side of the lens for 20 seconds, rinse each side of the lens for 5 seconds, and soak contact lens for at least 4 hours.
Intervention Type
Device
Intervention Name(s)
Galyfilcon A contact lenses (Acuvue Advance)
Other Intervention Name(s)
Acuvue® Advance®
Intervention Description
A fresh pair of contact lenses matching subject's pre-study lenses, including parameters, dispensed at the beginning of each period for daily wear, minimum 8 hours per day, 14 days.
Primary Outcome Measure Information:
Title
Lens Fit
Description
As assessed by the investigator using a composite score based on three lens fit measures: static, push-up, and centration. Static and pushup were assessed on a 5-point scale, where -2=reduced movement unacceptable, -1=reduced movement acceptable, 0=optimal movement, 1=excessive movement acceptable, 2=excessive movement unacceptable. Centration was assessed on a 3-point scale, where 0=optimal lens centration, 1=acceptable decentration, 2=unacceptable decentration. A subject with an assessment of optimal or acceptable for each measure was considered acceptable on all measurements.
Time Frame
Day 14 of lens wear
Secondary Outcome Measure Information:
Title
Mean Change From Baseline for Circumlimbal Conjunctival Staining Sum Score
Description
The bulbar conjunctiva was assessed by the investigator at baseline and Day 14 utilizing a slit-lamp and ophthalmic dye. Staining coverage was scored separately in each of four regions (nasal, temporal, inferior, and superior) using a 5-point photographic reference scale, where 0=0.00% coverage and 4=10% or greater coverage. The scores for the four regions were summed, with a sum score range of 0-16.
Time Frame
Day 14 of lens wear
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
18 years of age or older.
History of at least 5 days successful daily wear (minimum 8 hours per day) of spherical, single power Acuvue® Advance® SiH contact lenses prior to Visit 1.
Wear contact lenses a minimum of 8 hours per day prior to Visit 1.
Vision correctable to 20/30 (Snellen) or better in each eye at distance with study lenses at Visit 1.
Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
Need to wear contact lenses on an extended wear basis (i.e., overnight) during the study.
Use of products other than a multi-purpose solution to care for lenses at least 7 days prior to Visit 1. Pre-study use of rewetting drops is acceptable.
History of intolerance or known sensitivity to any component of the treatments.
Use of over-the-counter (OTC) or prescribed topical ocular medications within 7 days prior to Visit 1.
Other protocol-defined exclusion criteria may apply.
12. IPD Sharing Statement
Learn more about this trial
Clinical Performance of a Silicone Hydrogel Lens With Use of FID 114675A
We'll reach out to this number within 24 hrs